Jayne Shaw – Chairman
Jayne Shaw trained as a Registered Nurse in the UK, on arrival in Australia she became a Director of Nursing and Chief Executive Officer of two private hospitals. Following this she established an Australian and International consulting business which was sold to Healthsouth a large US Healthcare company. After this she became the Co-founder of Vision Group an Opthalmic Doctor equity consolidation model which was successfully listed on the ASX.
Jayne joined a number of private Healthcare Boards involved with specialist consolidation including Cardiology, Orthopaedics, and Women’s Health she continued to work with Private Equity firms on local and International Healthcare transactions. Jayne, together with Ron Phillips was a co-owner of Sydney Breast Clinic and a co-founder of BCAL Diagnostics.Current Board positions are Critical Group – Heatley’s Industrial Supplies, The Woolcock Research Institute, and The Hareda Foundation established to invest in Women’s Health Initiatives.
Carl Stubbings – Chief Executive Officer
Carl Stubbings is a highly qualified senior executive with over thirty years experience in biotechnology and medical diagnostics. His background includes manufacturing, administration, and extensive international sales and marketing expertise in North America, Latin America, Asia Pacific and Europe.
Prior positions include:
• Chief Business Officer Benitec Biopharma (ASX: BLT)
• Vice President Sales & Marketing for Focus Diagnostics a subsidiary of Quest Diagnostics (NASDAQ; DGX)
• Senior Vice President Panbio Ltd (USA)
• Current board appointments include Sienna Cancer Diagnostics (ASX: SDX)
In his role at Panbio (USA) and Focus Diagnostics, Carl led the commercialisation of number of medical diagnostic products. These achievements include the development and first FDA cleared test for West Nile Virus (Panbio USA). First FDA cleared molecular test for H1N1 (Influenza) and range of other ‘first in class’ molecular tests for viral diseases (Focus Diagnostics).
Prior to moving back to Australia, Carl and his family had lived and worked in the USA for more than 12 years.
Carl holds a B.App.Sc. from the Queensland University of Technology; he holds dual Australian and US citizenship.
Dr Amani Batarseh (PhD) – Chief Scientist
Dr Amani Batarseh is the company’s Senior Research Scientist. Amani graduated magna cum laude from La Roche College in Pennsylvania where she had a Pacem in Terris scholarship for academic excellence. Later, she received a fellowship to purse her PhD at Georgetown University, Washington, DC in Biochemistry and Molecular & Cellular Biology.
Amani completed post doctoral studies at Harvard University, McGill University and Wollongong University. During her time in Canada, Amani managed and established two mass spectrometry laboratories being at the Research Institute of McGill University Hospital and The Glen Hospital in Montreal, respectively. Her versatile profile of expertise combines molecular biology with lipidomics and mass spectrometry to answer biological questions.
The Hon Ron Phillips (AO) - Managing Director
Following 15 years in the NSW Parliament which included serving as Minister for Health and Deputy Leader of the Opposition, Ron developed a successful consulting business in the Health and Aged Care Industry.
His business interests included co-owner and Managing Director of Sydney Breast Clinic which he sold to Healthscope. He currently serves as Chair of the Sydney Local Health District and as Director on Westmead IVF.
Johnathan Trollip – Commercial Consultant
Jonathan is a globally experienced independent director with over 30 years commercial, corporate, governance and legal and transactional expertise.
Jonathan is currently non-executive independent chairman of ASX listed Global Value Fund Ltd Future Generation Investment Company Ltd , Antipodes Global Investment Company Ltd and Plato Income Maximizer Limited . He is a non-executive director of ASX listed Kore Potash Limited and holds private company directorships in the commercial and not-for-profit sectors.
Jonathan was a principal of Sydney, Australia based structured finance group Meridian International Capital Limited for over 20 years, Prior to that, Jonathan was a partner with law firm Herbert Smith Freehills. Jonathan currently has a New South Wales Law Society Practicing Certificate and is a Fellow of the Australian Institute of Company Directors.